PT-141 serves as a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound operates by activating specific receptors within the body, causing to improved sexual response. Clinical studies have revealed that PT-141 may remarkably treat a variety of sexual dysfunctions in both